scispace - formally typeset
J

Jiangnan Yu

Researcher at Jiangsu University

Publications -  148
Citations -  3257

Jiangnan Yu is an academic researcher from Jiangsu University. The author has contributed to research in topics: Bioavailability & Chemistry. The author has an hindex of 29, co-authored 129 publications receiving 2265 citations. Previous affiliations of Jiangnan Yu include China Pharmaceutical University.

Papers
More filters
Journal ArticleDOI

Enhanced Solubility and Bioavailability of Naringenin via Liposomal Nanoformulation: Preparation and In Vitro and In Vivo Evaluations.

TL;DR: It is indicated that the liposomal formulation significantly improved the solubility and oral bioavailability of naringenin, thus leading to wider clinical applications, and isopropyl myristate was very predominant in the liver.
Journal ArticleDOI

Improved oral bioavailability of capsaicin via liposomal nanoformulation: preparation, in vitro drug release and pharmacokinetics in rats

TL;DR: The results support the fact that Capsaicin, an effective drug for the treatment of neuropathic pain, could be encapsulated in liposome for improved oral bioavailability and the excellent IVIVC of capsaicin-loaded liposomes could also be a promising tool inliposomal formulation development with an added advantage of reduced animal testing.
Journal ArticleDOI

Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles

TL;DR: Sodium cholate/phospholipid-mixed micelles are promising carriers in orally delivery of silybin, considering their capability of enhancing bioavailability and large-scale production.
Journal ArticleDOI

Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo

TL;DR: Proliposomes may be a useful vehicle for oral delivery of dehydrosilymarin, a drug poorly soluble in water.
Journal ArticleDOI

A novel formulation of [6]-gingerol: Proliposomes with enhanced oral bioavailability and antitumor effect.

TL;DR: In vitro release of [6]-gingerol loaded proliposome compared with the free [6], was significantly higher and its oral bioavailability increased 5-fold in vivo, and its antitumor effect was enhanced in the liposome formulation.